SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...
Please provide your email address to receive an email when new articles are posted on . KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell ...
In the body there are two deep temporal arteries. These arteries are called the posterior and anterior deep temporal arteries. The anterior deep temporal artery and its partner are located between the ...
Results of a new study fuel the theory that the varicella-zoster virus (VZV), a herpesvirus linked to chickenpox in children and shingles (herpes zoster) in adults, also causes giant cell arteritis ...
Have your consultants ever seen a case of temporal arteritis present with an isolated C5 radiculopathy and peripheral (lower motor neuron) facial-nerve palsy one month prior to ocular findings?
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Senescence ...
A new point-of-care prediction tool that uses clinical and ultrasonography findings has good accuracy for identifying giant cell arteritis among patients seen in fast-track clinics. Investigators ...
Positive findings with color Doppler ultrasound were enough to diagnose giant cell arteritis (GCA) accurately without need for confirmation with temporal artery biopsy (TAB), a prospective study ...
Please provide your email address to receive an email when new articles are posted on . At the Congress on Controversies in Ophthalmology, Lee and Susan Mollan, MBChB, FRCOphth, PhD, debated this ...
Hosted on MSN
8 Temple Headache Causes and How to Ease the Pain
Temple headaches refer to pain in the temple area. However, the pain is caused by other headaches and conditions, such as tension headaches, migraines, temporal arteritis, infections, and jaw problems ...
NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ ® (upadacitinib), 15 mg, once daily, for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback